This inventor holds 2 USPTO granted patents. Top assignee: Sciclone Pharmaceuticals, Inc.. Active years: 2001-2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001-2002
Title: Innovations by David L Horwitz in Hepatitis B Treatment
Introduction
David L Horwitz is a notable inventor based in Hillsborough, CA (US), recognized for his contributions to medical science, particularly in the treatment of chronic hepatitis B. With a total of 2 patents to his name, Horwitz has made significant strides in enhancing therapeutic methods for this challenging condition.
Latest Patents
Horwitz's latest patents focus on a combination therapy method for treating chronic hepatitis B. The present invention aims to augment the success rate of using thymosin in the treatment of chronic hepatitis B by employing a combination therapy that utilizes thymosin alongside antiviral agents. These agents are effective in inhibiting DNA synthesis or DNA polymerase during the replication of the hepatitis B virus. This innovative approach holds promise for improving treatment outcomes for patients suffering from this viral infection.
Career Highlights
David L Horwitz is currently associated with SciClone Pharmaceuticals, Inc., where he continues to work on advancing therapeutic solutions in the field of infectious diseases. His expertise and dedication to research have positioned him as a key figure in the development of effective treatments for chronic hepatitis B.
Conclusion
David L Horwitz's innovative work in the field of hepatitis B treatment exemplifies the impact of dedicated research and invention in improving patient care. His contributions through patented methods highlight the importance of combining therapies to enhance treatment efficacy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile